✦ LIBER ✦

Sustained efficacy and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine up to 7.3 years in young adult women

✍ Scribed by N. De Carvalho; J. Teixeira; C.M. Roteli-Martins; P. Naud; P. De Borba; T. Zahaf; N. Sanchez; A. Schuind

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sustained efficacy and immunogenicity of

📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 248 KB

Immunogenicity and tolerability of an HP

✍ Tino F. Schwarz; Marek Spaczynski; Achim Schneider; Jacek Wysocki; Andrzej Galaj 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 653 KB

O929 Sustained levels of total and neutr

✍ De Carvalho, N.; Roteli-Martins, C.; Teixeira, J.; Naud, P.; De Borba, P.; Zahaf 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Efficacy of the human papillomavirus (HP

✍ A. Szarewski; W.A.J. Poppe; S.R. Skinner; C.M. Wheeler; J. Paavonen; P. Naud; J. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 857 KB

O180 SAFETY AND IMMUNOGENICITY OF THE HP

✍ Denny, L.; Hendricks, B.; Gordon, C.; Hervé, C.; Thomas, F.; Hezareh, M.; Dobbel 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 127 KB

Immunogenicity and safety of human papil

✍ Neerja Bhatla; Vanita Suri; Partha Basu; Surendra Shastri; Sanjoy K. Datta; Dan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 977 KB